Table 1.

Characteristics and Clinical Management of all Patients treated for Breast Cancer.

Characteristic (n = 164)	Number (%)
Median age at presentation, range (n = 164)	50, 30–93 years
Referral (n = 164)a
Yes	74 (45%)
No	90 (55%)
Mwanza City Residence (n = 164)b
Yes	34 (21%)
No	130 (79%)
Insurance (n = 164)
Yes	50 (30%)
No	114 (70%)
Menopause Status (n = 164)
Pre-menopausal	61 (37%)
Post-menopausal	70 (43%)
Not reported	33 (20%)
Breast Symptoms at Presentation (n = 164)
Yes	164 (100%)
No	0 (0%)
Clinically Positive Nodes Reported (n = 164)
Suspected	23 (14%)
Not suspectedc	141 (86%)
Suspected Distant Metastases (n = 164)
Yes	26 (16%)
No	138 (84%)
Surgery (n = 164)
Yes	135 (82%)
No	29 (18%)
Surgical Procedure (n = 135)
Excision/Lumpectomy	25 (19%)
Unilateral Mastectomy	88 (65%)
Bilateral Mastectomy	4 (3%)
Other/Unknown	18 (13%)
Axillary evaluation (n = 135)
Yes	75 (56%)
No	60 (44%)
Chemotherapy prescribed (n = 164)
Yes	103 (63%)
No	61 (37%)
Chemotherapy basis (n = 103)
Proven histopathology	57 (56%)
Symptoms	2 (2%)
Other (imaging, FNAC, clinical suspicion)	43 (42%)
Chemotherapy Received (n = 103)
Yes	81 (79%)
No	22 (21%)
Hormone therapy (n = 164)
Yes	63 (38%)
No	101 (62%)
Basis for hormone therapy (n = 63)
Proven receptor status	9 (15%)
Clinical suspicion	54 (86%)
Radiation therapy (n = 164)
Yes	5 (3%)
No	197 (97%)
Adjuvant therapyd
Yes	100 (61%)
Chemotherapy	81 (81%)
No	64 (39%)

^a Defined as referral slip present in chart or mention of referral in clinical notes, ^b Defined as residence in districts of Nyamagana and Ilemela. ^c Includes those with no documented clinical axillary exam recorded, ^d Includes chemotherapy, hormone therapy, and radiation therapy

FNAC: fine needle aspiration cytology